Double-step PCR assay to quantify Epstein-Barr viral load in peripheral blood

Applied Biochemistry and Biotechnology - Part B Molecular Biotechnology

Volumn 27, Issue 3, 2004, Pages 187-195

  Bergallo, Massimiliano ^a   Merlino, Chiara ^a   Daniele, Roberta ^a   Sinesi, Franca ^a   Fumagalli, Mara ^a   Ponzi, Alessandro Negro ^a   Cavallo, Rossana ^a  

^a UNIVERSITY OF TURIN   (Italy)

Author keywords

EBV; Quantitative competitive PCR; Renal transplantation; Viral load

Indexed keywords

BIOASSAY; BIOLOGICAL ORGANS; DNA; GENES; PATIENT TREATMENT; TRANSPLANTATION (SURGICAL); VIRUSES;

EBV; EPSTEIN-BARR VIRUS (EBV); POSTTRANSPLANT LYMPHOPROLIFERATIVE DISORDERS (PTLD); QUANTITATIVE-COMPETITIVE PCR; RENAL TRANSPLANTATION; VIRAL LOAD;

BIOCHEMISTRY;

VIRUS DNA;

ADULT; ANALYTIC METHOD; ARTICLE; BLOOD SAMPLING; CLINICAL ARTICLE; CONTROLLED STUDY; COST BENEFIT ANALYSIS; DNA DETERMINATION; EPSTEIN BARR VIRUS; FEMALE; GENE NUMBER; HUMAN; INFECTION RISK; KIDNEY TRANSPLANTATION; MALE; PATIENT MONITORING; PERIPHERAL BLOOD MONONUCLEAR CELL; POLYMERASE CHAIN REACTION; POSTOPERATIVE INFECTION; PROCESS DEVELOPMENT; QUANTITATIVE ANALYSIS; RISK ASSESSMENT; SAMPLE; SCREENING; VIRUS GENOME; VIRUS INFECTION; VIRUS LOAD; BLOOD; CELL CULTURE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; GENETICS; ISOLATION AND PURIFICATION; METHODOLOGY; MIDDLE AGED; MONONUCLEAR CELL; RANDOMIZED CONTROLLED TRIAL; REPRODUCIBILITY; SENSITIVITY AND SPECIFICITY; VALIDATION STUDY; VIROLOGY;

DNA VIRUSES; HUMAN HERPESVIRUS 4;

CELLS, CULTURED; DNA, VIRAL; EPSTEIN-BARR VIRUS INFECTIONS; FEMALE; HERPESVIRUS 4, HUMAN; HUMANS; LEUKOCYTES, MONONUCLEAR; MALE; MIDDLE AGED; POLYMERASE CHAIN REACTION; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; VIRAL LOAD;

EID: 16644383064     PISSN: 10736085     EISSN: None     Source Type: Journal    
DOI: 10.1385/MB:27:3:187     Document Type: Article

References (50)

1. Starzl, T. E., Nalesnik, M. A., Porter, K. A., et al. (1984) Reversibility of lymphomas and lymphoproliferative lesions developing under cyclosporin-steroid therapy. Lancet 1, 583-587.
2. Armitage, J. M., Kormos, R. L., Stuart, R. S., et al. (1991) Posttransplant lymphoproliferative disease in thoracic organ transplant patients: ten years of cyclosporine-based immunosuppression. J. Heart Lung Transplant 10, 877-886.
3. Alfrey, E. J., Friedman, A. L., Grossman, R. A., et al. (1992) A recent decrease in the time to development of monomorphous and polymorphous post-transplant lymphoproliferative disorder. Transplantation 54, 250-253.
4. Craig, F. E., Gulley, M. L., and Banks, P. M. (1993) Post-transplantation lymphoproliferative disorders. Am. J. Clin. Pathol. 99, 265-276.
5. Nalesnik, M. A. (1996) Posttransplantation lympho-proliferative disorders (PTLD): current perspectives. Semin. Thorac. Cardiovasc. Surg. 8, 139-148.
6. Wagner, H. J., Wessel, M., Jabs, W., et al. (2001) Patients at risk for development of postransplant lymphoproliferative disorder: plasma versus peripheral blood mononuclear cells as material for quantification of Epstein-Barr viral load by using real-time quantitative polymerase chain reaction. Transplantation 72, 1012-1019.
7. Boubenider, S., Hiesse, C., Goupy, C., Kriia, F., Marchand, S., and Charpentier, B. (1997) Incidence and consequences of post-transplant lymphoproliferative disorders. J. Nephrol. 10, 136-145.
8. Mamzer-Bruneel, M. F., Bourquelot, P., Hermine, O., Legendre, C., and Kreis, H. (1997) Treatment and prognosis of post-transplant lymphoproliferative disease. Ann Transplant 2, 42-48.
9. Swinnen, L. J. (2000) Diagnosis and treatment of transplant-related lymphoma. Ann Oncol. 11(Suppl 1), 45-48.
10. Hanto, D. W., Sakamoto, K., Purtilo, D. T., Simmons, R. L., and Najarian, J. S. (1981) The Epstein-Barr virus in the pathogenesis of posttransplant lymphoproliferative disorders: clinical, pathologic and virologic correlation. Surgery 90, 204-213.
11. Hanto, D. W., Frizzera, G., Gail-Peczalska, K. J., and Simmons, R. L. (1985) EB virus, immunodeficiency and B cell lymphoproliferation. Transplantation 39, 461-472.
12. Ho, M., Miller, G., Atchison, R. W., et al. (1985) Epstein-Barr virus infection and DNA hybridisation studies in post-transplantation lymphoma and lymphoproliferative lesions: the role of primary infection. J. Infect. Dis. 152, 876-886.
13. Ho, M., Jaffe, R., Miller, G., et al. (1988) The frequency of Epstein-Barr virus infection and associated lymphoproliferative syndrome after transplantation and its manifestations in children. Transplantation. 45, 719-727.
14. Swinnen, L. J., Costanzo-Nordin, M. R., Fisher, S. G., et al. (1990) Increased incidence of lymphoproliferative disorder after immunosuppression with the monoclonal antibody OKT3 in cardiac-transplant recipients. N. Engl. J. Med. 323, 1723-1728.
15. Cockfield, S. M., Preiksaitis, J., Harvey, E., et al. (1991) Is sequential use of ALG and OKT3 in renal transplants associated with an increased incidence of fulminant posttransplant lymphoproliferative disorder? Transplant Proc. 23, 1106-1109.
16. Ho, M. (1995) Risk factors and pathogenesis of post-transplant lymphoproliferative disorders. Transplant Proc. 27 (Suppl 1), 38-40.
17. Lucas, K. G., Pollok, K. E., and Emanuel, D. J. (1997) Post-transplant EBV induced lymphoproliferative disorders. Leuk. Lymphoma 25, 1-8.
18. Nalesnik, M. A. (1998) Clinical and pathologic features of post-transplant lymphoproliferative disorders (PTLD). Springer Semin. Immunopathol. 20, 325-342.
19. Swerdlow, A. J., Higgings, C. D., Hunt, B. J., et al. (2000) Risk of lymphoid neoplasia after cardiothoracic transplantation: a cohort study of the relation to Epstein-Barr virus infection. Transplantation. 69, 897-904.
20. Rickinson, A. B. and Kieff, E. (2001) Epstein-Barr virus. In Fields Virology, vol. 2. Knipe, D. M. and Howley, P. M., eds. Lippincott Williams and Wilkins, Philadelphia, pp. 2575-2628.
21. Telenti, A., Marshall, W. F., and Smith, T. F. (1990) Detection of Epstein-Barr virus by polymerase chian reaction. J. Clin. Microbiol. 28, 2187-2190.
22. Riddler, S. A., Breinig, M. C., and Mcknight, J. L. C. (1994) Increased levels of circulating Epstein-Barr virus (EBV)-infected lymphocytes and decreased EBV nuclear antigen antibody responses are associated with the development of post-transplant lymphoproliferative disease in solid-organ transplant recipient. Blood 84, 972-984.
23. Savoie, A., Perpete, C., Carpentier, L., Joncas, J., and Alfieri, C. (1994) Direct correlation between the load of Epstein-Barr virus-infected lymphocytes in the peripheral blood of pediatric transplant patients and risk of lymphoproliferative disease. Blood 83, 2715-2722.
24. Green, M., Cacciarelli, T. V., Mazariegos, G. V., et al. (1998) Serial measurement of Epstein-Barr viral load in peripheral blood in pediatric liver transplant recipient during treatment for posttransplant lymphoproliferative disease. Transplantation 66, 1641-1644.
25. Orentas, R. J. (1998) Determination of Epstein-Barr virus (EBV) load by RT-PCR and cellular dilution. Mol. Cell Probes. 12, 427-430.
26. Drouet, E., Brousset, P., Fares, F., et al. (1999) High Epstein-Barr virus serum load and elevated titers of anti-ZEBRA antibodies in patients with EBV-harboring tumor cells of Hodgkin's disease. J. Med. Virol. 57, 383-389.
27. Baldanti, F., Grossi, P., Furione, M., et al. (2000) High levels of Epstein-Barr virus DNA in blood of solid-organ transplant recipients and their value in predicting posttransplant lymphoproliferative disorders. J. Clin. Microbiol. 38, 613-619.
28. Kenagy, D. N., Schlesinger, Y., Weck, K., Ritter, J. H., Gaudreault-Keener, M. M., and Storch, G. A. (1995) Epstein-Barr virus DNA in peripheral blood leukocytes of patients with post-transplant lymphoproliferative disease. Transplantation 60, 547-554.
29. Wagner, H. J., Fischer, L., Jabs, W., Holbe, M., Pethig, K., and Bucksy, P. (2002) Longitudinal analysis of Epstein-Barr viral load in plasma and peripheral blood mononuclear cells of transplanted patients by real time polymerase chain reaction. Transplantation 74, 656-664.
30. Cheung, A. and Kieff, E. (1982) Long internal direct repeat in Epstein-Barr virus DNA. J. Virol. 44, 286-294.
31. Wakefield, A. J., Fox, J. D., Sawyer, A. M., et al. (1992) Detection of herpesvirus DNA in the large intestine of patients with ulcerative colitis and Crohn's disease using the nested polymerase chain reaction. J. Med. Virol. 38, 183-190.
32. Merlino, C., Bergallo, M., Gribaudo, G., et al. (2003) Polyomavirus BK DNA quantification assay to evaluate viral load in renal transplant recipients. J. Clin. Virol. 28, 265-274.
33. Rowe, D. T., Qu, L., Reyes, J., et al. (1997) Use of quantitative competitive PCR to measure Epstein-Barr virus genome load in the peripheral blood of pediatric transplant patient with lymphoproliferative disorders. J. Clin. Microbiol. 35, 1612-1615.
34. Kimura, H., Morita, M., Yabuta, Y., et al. (1999) Quantitative analysis of Epstein-Barr virus load by using a real-time PCR assay. J. Clin. Microbiol. 37, 132-136.
35. Niesters, H. G., Van Esser, J., Fries, E., Wolthers, K. C., Cornelissen, J., and Osterhaus, A. D. (2000) Development of a real-time quantitative assay for detection of Epstein-Barr virus. J. Clin. Microbiol. 38, 712-715.
36. Yang, J., Tao, Q., Flinn, I. W., et al. (2000) Characterization of Epstein-Barr virus-infected B cells in patients with posttransplantation lymphoproliferative disease: disappearance after rituximab therapy does not predict clinical response. Blood 96, 4055-4063.
37. Jabs, W. J., Hennig, H., Kittel, M., et al. (2001) Normalized quantification by real-time PCR of Epstein-Barr virus load in patients at risk for post-transplant lymphoproliferative disorders. J. Clin. Microbiol. 39, 564-569.
38. Stevens, S. J., Verschuuren, E. A., Pronk, I., et al. (2001) Frequent monitoring of Epstein-Barr virus DNA load in unfractionated whole blood is essential for early detection of posttransplant lymphoproliferative disease in high-risk patients. Blood 97, 1165-1171.
39. Kellogg, D. E., Sninsky, J. J., and Kwok, S. Quantitation of HIV-1 proviral DNA relative to cellular DNA by the polymerase chain reaction. (1990) Anal. Biochem. 189, 202-208.
40. Ballagi-Pordàny, A., Ballagi-Pordàny, A., and Funa, K. (1991) Quantitative determination of mRNA phenotypes by the polymerase chain reaction. Anal. Biochem. 196, 89-94.
41. Dickover, R. E., Donovan, R. M., Goldstein, E., Dandekar, S., Bush, C. E., and Carlson, J. R. (1990) Quantitation of human immunodeficiency virus DNA by using the polymerase chain reaction. J. Clin. Microbiol. 28, 2130-2133.
42. Poli, F., Cattaneo, R., Crespiatico, L., Nocco, A., and Sirchia, G. (1993) A rapid and simple method for reversing the inhibitory effect of heparin on PCR for HLA class II typing. PCR Methods Appl. 2, 356-358.
43. Zipeto, D., Baldanti, F., Zella, D., et al. Quantification of human cytomegalovirus DNA in peripheral blood polymorphonuclear leukocytes of immunocompromised patients by the polymerase chain reaction. (1993) J. Virol. Methods 44, 45-56.
44. Linz, U. (1990) Thermocycler temperature variation invalidates PCR results. Biotechniques 9, 286-293.
45. Gibson, U. E., Heid, C. A., and Williams, P. M. (1996) A novel method for real time quantitative RT-PCR. Genome Res. 6, 995-1001.
46. Heid, C. A., Stevens, J., Livak, K. J., and Williams, P. M. (1996) Real time quantitative PCR. Genome Res. 6, 986-994.
47. Storch, G. A. (2001) Diagnostic virology. In Fields Virology, vol. 1. Knipe D. M. and Howley P. M. (eds.). Lippincott Williams and Wilkins, Philadelphia, pp. 493-531.
48. Fox, J. C., Griffiths, P. D., and Emery, V. C. (1992) Quantification of human cytomegalovirus DNA using the polymerase chain reaction. J. Gen. Virol. 73, 2405-2408.
49. Diviacco, S., Norio, P., Zentilin, L., et al. (1992) A novel procedure for quantitative polymerase chain reaction by coamplification of competitive templates. Gene 122, 313-320.
50. Menzo, S., Bagnarelli, P., Giacca, M., Manzin, A., Varaldo, P. E., and Clementi, M. (1992) Absolute quantitation of viremia in human immunodeficiency virus infection by competitive reverse transcription and polymerase chain reaction. J. Clin. Microbiol. 30, 1752-1757.